journal article·2022-09

Parallelism to Conquer: Binary Supramolecular Peptide Amphiphiles Launch Synergistic Stromal Reprogramming to Remove the Baffle in Pancreatic Cancer Therapy

Weiqi Zhang, Jie Zhan, Ruizhi Zhao, Yangping Xu, Yinghua Zeng, Qiuqun Xiao, Wenyu Ye, Yuanyuan Wu, Yanbin Cai, Chihua Fang

Advanced Functional Materials· Volume 32· Issue 38
Publisher page

Abstract

Abstract In pancreatic cancer, the activation of quiescent pancreatic stellate cells (PSCs) is a critical event that leads to a characteristic dense desmoplastic stroma. The fibrotic network resulting from the bidirectional cross talk between pancreatic cancer cells (PCCs) and PSCs creates a complex tumor microenvironment that considerably hinders drug delivery and penetration. To improve pancreatic cancer treatment, a promising parallelization strategy with cross‐action property is urgently required that can simultaneously act on PCCs and PSCs to normalize activated PSCs (aPSCs), that is reverse them back to quiescent phenotype. Herein, a novel parallelization delivery system (CoA‐A&B‐γPGA) with dual‐pathway PSC quiescence restoration functions is designed. Metformin downregulates the secretion of transforming growth factor‐beta in PCCs, and all‐trans‐retinoic acid re‐educates aPSCs. CoA‐A&B‐γPGA thus induces aPSC quiescence and homeostatic restoration of desmoplastic stroma in vitro and in vivo. Importantly, CoA‐A&B‐γPGA exhibits deep penetration, improved accumulation and long‐term retention, and enhanced combination chemotherapy effects in multicellular spheroid and xenograft models. Furthermore, this dual‐targeting and co‐delivery system shows high specificity and sensitivity for detecting pancreatic cancer in patient samples. The innovative but simple peptide amphiphile co‐assembly strategy provides a new paradigm to design desired nanomedicines for stroma‐enriched pancreatic cancer therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Supramolecular Self-Assembly in Materials · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Hepatobiliary Surgery, Institute of Digital Intelligence Zhujiang Hospital Southern Medical University Guangzhou 510280 P. R. China

Guangdong Provincial Clinical and Engineering Center of Digital Medicine Guangzhou 510280 P. R. China

Pazhou Lab Guangzhou 510320 P. R. China

Department of Laboratory Medicine, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors Nanfang Hospital, Southern Medical University Guangzhou 510515 P. R. China

Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease Department of Cardiology and Laboratory of Heart Center Zhujiang Hospital Southern Medical University Guangzhou 510280 P. R. China

Department of Pediatric Hematology Zhujiang Hospital Southern Medical University Guangzhou 510280 P. R. China

Guangdong Provincial Key Laboratory of New Drug Screening School of Pharmaceutical Sciences Southern Medical University Guangzhou 510515 P. R. China

Funding

National Basic Research Program of China · National Natural Science Foundation of China

References (43)

Show source-provided references
1. 10.1001/jama.2021.1302710.1001/jama.2021.13027 ↗
2. 10.1016/S0140-6736(20)30974-010.1016/S0140-6736(20)30974-0 ↗
3. 10.3322/caac.2170810.3322/caac.21708 ↗
4. 10.1038/s41590-020-0761-y10.1038/s41590-020-0761-y ↗
5. 10.1038/s41571-020-0363-510.1038/s41571-020-0363-5 ↗
6. 10.1038/s41575-020-0300-110.1038/s41575-020-0300-1 ↗
7. 10.1016/j.ejphar.2014.07.04110.1016/j.ejphar.2014.07.041 ↗
8. 10.1084/jem.2016202410.1084/jem.20162024 ↗
9. 10.1158/2159-8290.CD-18-071010.1158/2159-8290.CD-18-0710 ↗
10. 10.1038/s41568-019-0238-110.1038/s41568-019-0238-1 ↗
11. 10.1016/j.ccell.2021.02.00710.1016/j.ccell.2021.02.007 ↗
12. 10.1016/j.trecan.2019.01.00110.1016/j.trecan.2019.01.001 ↗
13. 10.1136/gutjnl-2016-31195410.1136/gutjnl-2016-311954 ↗
14. 10.1038/nmat379210.1038/nmat3792 ↗
15. 10.1016/j.ccr.2014.04.00510.1016/j.ccr.2014.04.005 ↗
16. 10.3390/cancers1206147610.3390/cancers12061476 ↗
17. 10.1038/s41467-018-05906-x10.1038/s41467-018-05906-x ↗
18. 10.1158/1078-0432.CCR-13-342610.1158/1078-0432.CCR-13-3426 ↗
19. 10.1186/s12943-018-0927-510.1186/s12943-018-0927-5 ↗
20. 10.1016/j.canlet.2016.10.01910.1016/j.canlet.2016.10.019 ↗
21. 10.1038/ncomms1263010.1038/ncomms12630 ↗
22. 10.1038/s41586-022-04437-210.1038/s41586-022-04437-2 ↗
23. 10.1039/C8CS00115D10.1039/C8CS00115D ↗
24. 10.1016/j.addr.2021.04.02410.1016/j.addr.2021.04.024 ↗
25. 10.1016/j.addr.2016.08.00510.1016/j.addr.2016.08.005 ↗
26. 10.1016/j.bioactmat.2021.07.02110.1016/j.bioactmat.2021.07.021 ↗
27. 10.1002/anie.20201427810.1002/anie.202014278 ↗
28. 10.1002/adhm.20180089910.1002/adhm.201800899 ↗
29. 10.1016/j.bioactmat.2019.01.00210.1016/j.bioactmat.2019.01.002 ↗
30. 10.1002/bip.2132810.1002/bip.21328 ↗
31. 10.1021/acs.accounts.7b0029710.1021/acs.accounts.7b00297 ↗
32. 10.1002/adhm.20180154510.1002/adhm.201801545 ↗
33. 10.1002/adhm.20200121110.1002/adhm.202001211 ↗
34. 10.1038/s41467-019-14036-x10.1038/s41467-019-14036-x ↗
35. 10.1021/acs.nanolett.8b0187910.1021/acs.nanolett.8b01879 ↗
36. 10.1007/s13238-019-0639-710.1007/s13238-019-0639-7 ↗
37. 10.1038/srep1672810.1038/srep16728 ↗
38. Yang P. · Adv. Mater. · 2017 · 29
39. Skoulas D. · Polymers · 2017 · 9
40. 10.1021/jacs.0c0065010.1021/jacs.0c00650 ↗
41. 10.1186/s13045-020-00931-010.1186/s13045-020-00931-0 ↗
42. 10.1038/nm.397310.1038/nm.3973 ↗
43. 10.1158/2159-8290.CD-18-034910.1158/2159-8290.CD-18-0349 ↗